Advertisement

Diabetologia

, Volume 39, Issue 3, pp 368–370 | Cite as

The effect of cholesterol-lowering therapy on the progression of diabetic nephropathy is unproved

  • R. Bender
  • K. S. L. Lam
  • I. J. Lauder
Letter to the Editors

Keywords

Public Health Internal Medicine Human Physiology Metabolic Disease Diabetic Nephropathy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lam KSL, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604–609Google Scholar
  2. 2.
    Andersen B (1990) Methodological errors in medical research. Blackwell, Oxford London Edinburgh Boston Melbourne Paris Berlin ViennaGoogle Scholar
  3. 3.
    Crowder MJ, Hand DJ (1990) Analysis of repeated measures. Chapman and Hall, London New York Tokyo Melbourne MadrasGoogle Scholar
  4. 4.
    Senn S (1994) Testing for baseline balance in clinical trials. Stat Med 13: 1715–1726Google Scholar
  5. 5.
    Matthews JNS, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300: 230–235Google Scholar

References

  1. 1a.
    Lam KSL, Cheng IKP, Janus ED, Pang RWC (1995) Cholesterol-lowering therapy may retard the progression of diabetic nephropathy. Diabetologia 38: 604–609Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • R. Bender
    • 1
  • K. S. L. Lam
    • 2
  • I. J. Lauder
    • 2
  1. 1.Department of Metabolic Diseases and NutritionHeinrich-Heine-Universität DüsseldorfDüsseldorfGermany
  2. 2.Departments of MedicineThe University of Hong KongHong Kong

Personalised recommendations